- Home
- CFFI vs SERA Comparison
CFFI vs SERA Comparison
Compare CFFI & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFI
- SERA
- Stock Information
- Founded
- CFFI 1927
- SERA 2008
- Country
- CFFI United States
- SERA United States
- Employees
- CFFI N/A
- SERA N/A
- Industry
- CFFI Major Banks
- SERA Precision Instruments
- Sector
- CFFI Finance
- SERA Health Care
- Exchange
- CFFI Nasdaq
- SERA Nasdaq
- Market Cap
- CFFI 249.4M
- SERA 208.7M
- IPO Year
- CFFI 1998
- SERA 2021
- Fundamental
- Price
- CFFI $74.92
- SERA $6.11
- Analyst Decision
- CFFI
- SERA
- Analyst Count
- CFFI 0
- SERA 0
- Target Price
- CFFI N/A
- SERA N/A
- AVG Volume (30 Days)
- CFFI 8.6K
- SERA 89.2K
- Earning Date
- CFFI 10-29-2024
- SERA 11-06-2024
- Dividend Yield
- CFFI 2.31%
- SERA N/A
- EPS Growth
- CFFI N/A
- SERA N/A
- EPS
- CFFI 5.66
- SERA N/A
- Revenue
- CFFI $114,783,000.00
- SERA $94,000.00
- Revenue This Year
- CFFI N/A
- SERA N/A
- Revenue Next Year
- CFFI N/A
- SERA $2,018.04
- P/E Ratio
- CFFI $13.17
- SERA N/A
- Revenue Growth
- CFFI N/A
- SERA N/A
- 52 Week Low
- CFFI $33.51
- SERA $1.81
- 52 Week High
- CFFI $76.13
- SERA $12.36
- Technical
- Relative Strength Index (RSI)
- CFFI 70.39
- SERA 39.97
- Support Level
- CFFI $71.04
- SERA $5.94
- Resistance Level
- CFFI $75.00
- SERA $6.34
- Average True Range (ATR)
- CFFI 2.84
- SERA 0.67
- MACD
- CFFI 0.59
- SERA -0.16
- Stochastic Oscillator
- CFFI 92.59
- SERA 7.29
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum revenue from the Community Banking segment.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.